Articles in English

Donald Trump appeared alone on the cover of Forbes magazine for the first time on May 14, 1990. The story inside offered a devastating look at his finances

Sweden's deputy director of public prosecution Eva-Marie Persson spoke during a press conference on May 13, 2019 in Stockholm to announce the reopening a 2010 rape investigation against WikiLeaks founder Julian Assange

OXFORD – Elections and referenda are just two ways for people to have a say in how they are governed. Protesting is another, which is why rights of assembly and free speech are protected in most democracies

Over the past two weeks, Robert Iger, the CEO of Disney, has made headlines not for Disney’s Avengers box office performance or for his completion of the Disney-Fox merger, but for something more personal: his $65.6 million salary—an amount that Disney heir Abigail Disney recently called “insane”

FRANKFURT – Between Lake Geneva and the Swiss Jura, more than 100 meters (328 feet) below the surface, lies a circular tunnel, 27 kilometers (17 miles) in circumference, containing superconducting magnets that accelerate protons almost to the speed of light. At four locations in the tunnel, the protons are made to collide. Particle physicists observe these collisions, in an effort to learn what matter is made of and what holds it together.

NEW HAVEN – In a rare moment of bipartisan agreement, America’s Republicans and Democrats are now on the same page on one key issue: Blaming China for all that ails the United States. China bashing has never had broader appeal

BUENOS AIRES – Argentina first needed to borrow from the International Monetary Fund back in 1958. In the six decades since, the country has signed 22 agreements with the Fund. Most were subsequently derailed or ended in failure

It seems puzzling at first: prescription drug prices in the United States continue to rise at an alarming rate, despite the threat (or promise) of competition from cheaper generic substitutes. But there really is no mystery. Pharmaceutical companies pay players throughout the health-care system to favor their more expensive drugs over lower-priced alternatives. And those who should be acting as watchdogs for patients are happy to go along